A5073415541- Cancer Diagnosis and Treatment
- Cervical Cancer and HPV Research
- Eosinophilic Disorders and Syndromes
- Mast cells and histamine
- Ear and Head Tumors
- Nonmelanoma Skin Cancer Studies
- Colorectal Cancer Treatments and Studies
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Treatments and Mutations
- Head and Neck Cancer Studies
- Colorectal and Anal Carcinomas
- Autoimmune Bullous Skin Diseases
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Global Public Health Policies and Epidemiology
- Chronic Myeloid Leukemia Treatments
- Oral Health Pathology and Treatment
- Hepatitis B Virus Studies
Eisenhower Medical Center
2024
Federal Ministry of Health
2015-2018
Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR) are linked with side effects involving skin and mucosa. Herein, we present a unique case of oral lichenoid drug eruption (LDE) in patient treated osimertinib.
Welcome to Annals of Global Health,Annals Health is a peer-reviewed, fully open access, online journal dedicated publishing high quality articles all aspects global health. The journal's mission advance health, promote research, and foster the prevention treatment disease worldwide. Its goals are improve health well-being people, equity, wise stewardship earth's environment. latest impact factor 3.64.Annals supported by Program for Public Common Good at Boston College. It was founded in 1934...
Introduction Careful adverse event assessment and management are important when prescribing immune checkpoint inhibitors (ICIs) to cancer patients. Iatrogenic Sjogren's syndrome is a relatively rare immune-related (irAEs) that affects the moisture-producing glands. Methods We describe series of four patients who developed while being treated with ICIs at community center in Southern California, USA (1/1/2017–12/31/2023). Patient, drug disease-related data were collected by retrospective...
Employed in the treatment of malignancies and non-neoplastic conditions, hydroxyurea is associated with integumentary adverse effects, including skin discoloration, xerosis, pruritus, cutaneous atrophy, chronic leg ulcers, oral ulcerations, alopecia, some nail abnormalities.
Introduction 5-azacitidine is a hypomethylating agent (HMA) used for treating myelodysplastic syndrome (MDS) and certain myeloproliferative neoplasms (MPNs). Common side effects include myelosuppression, nausea injection site reactions. Serious allergic reactions are rare with this class of agents. Case Report We describe 71-year-old man MDS/MPN who developed repeated episodes angioedema after starting treatment subcutaneous 5-azacitidine. Angioedema involved multiple body areas including...
Vermillion lip squamous cell carcinoma (SCC) is a rare cancer, currently grouped together with the cutaneous under (cSCC) system. Herein, we present case of an 81-year-old male locally advanced lower SCC involving vermillion who achieved complete pathologic response to neoadjuvant cetuximab after failure programed death protein-1 (PD-1) inhibitor, cemiplimab. He was followed clinical observation, special attention skin/mucosal surfaces. At 24-week follow-up visit, he had no signs recurrence...